Discover
TMDX
TransMedics Group, Inc.
86.35
1 x 86.20
1 x 86.36
bid
ask
-
2.06
2.33%
01:34 PM
timesize
| Ytd | -29.02% | |
| 1y | -32.15% |
85.81
day range
87.74
60.10
52 week range
156.00
| Open | 87.70 | Prev Close | 88.41 | Low | 85.81 | High | 87.74 | Mkt Cap | 2.98B |
| Vol | 334.31K | Avg Vol | 1.16M | EPS | 1.97 | P/E | 43.83 | Forward P/E | 35.34 |
| Beta | 1.90 | Short Ratio | 7.24 | Inst. Own | 110.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 73.88 | 200-d Avg | 108.08 | 1yr Est | 97.30 |
| Income Statement | |||
| Total Revenue | 189.95M | ||
| Revenues (USD) | 189.95M | ||
| Cost of Revenue | 76.75M | ||
| Gross Profit | 113.20M | ||
| Operating Expenses | 89.46M | ||
| Research and Development Expense | 31.63M | ||
| Selling, General and Administrative Expense | 57.83M | ||
| Operating Income | 23.74M | ||
| Interest Expense | 7.23M | ||
| Income Tax Expense | 4.72M | ||
| Net Income | 14.68M | ||
| Net Income Common Stock | 14.68M | ||
| Net Income Common Stock (USD) | 14.68M | ||
| Consolidated Income | 14.68M | ||
| Earnings per Basic Share | 0.42 | ||
| Earnings per Basic Share (USD) | 0.42 | ||
| Earnings per Diluted Share | 0.41 | ||
| Earning Before Interest & Taxes (EBIT) | 26.63M | ||
| Earning Before Interest & Taxes (USD) | 26.63M | ||
| Weighted Average Shares | 34.58M | ||
| Weighted Average Shares Diluted | 40.71M | ||
| Balance Sheet | |||
| Cash and Equivalents | 491.11M | ||
| Cash and Equivalents (USD) | 491.11M | ||
| Trade and Non-Trade Receivables | 104.14M | ||
| Current Assets | 651.12M | ||
| Property, Plant & Equipment Net | 702.42M | ||
| Total Assets | 1.46B | ||
| Debt Current | 23.65M | ||
| Total Debt | 867.72M | ||
| Current Liabilities | 98.28M | ||
| Debt Non-Current | 844.07M | ||
| Total Liabilities | 946.34M | ||
| Accumulated Retained Earnings (Deficit) | -255.95M | ||
| Accumulated Other Comprehensive Income | -210.00K | ||
| Shareholders Equity | 518.05M | ||
| Shareholders Equity (USD) | 518.05M | ||
| Assets Non-Current | 813.27M | ||
| Total Debt (USD) | 867.72M | ||
| Deferred Revenue | 3.13M | ||
| Goodwill and Intangible Assets | 11.55M | ||
| Inventory | 54.14M | ||
| Liabilities Non-Current | 848.06M | ||
| Trade and Non-Trade Payables | 12.91M | ||
| Tax Assets | 78.68M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 10.86M | ||
| Net Cash Flow from Financing | 970.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 10.94M | ||
| Capital Expenditure | -7.09M | ||
| Issuance (Purchase) of Equity Shares | 1.01M | ||
| Net Cash Flow from Investing | -7.09M | ||
| Net Cash Flow from Operations | 17.31M | ||
| Effect of Exchange Rate Changes on Cash | -251.00K | ||
| Share Based Compensation | 8.61M | ||